Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
aTYR PHARMA INC (LIFE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 4% stake in aTyr Pharma, Inc. |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 15% stake in ATYR PHARMA INC |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 18% stake in ATYR PHARMA, INC. |
| 02/14/2022 |
SC 13G/A
| Ikarian Capital, LLC reports a |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 5.6% stake in aTyr Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Alyeska Investment Group, L.P. reports a 0% stake in aTyr Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 18.8% stake in ATYR PHARMA, INC. |
| 02/09/2022 |
SC 13G/A
| FMR LLC reports a 15% stake in ATYR PHARMA INC |
| 10/08/2021 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 19.9% stake in ATYR PHARMA, INC. |
| 07/12/2021 |
SC 13G/A
| FMR LLC reports a 10.4% stake in ATYR PHARMA INC |
| 04/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
SC 13G/A
| FMR LLC reports a 12.6% stake in ATYR PHARMA INC |
| 01/14/2020 |
SC 13G/A
| Alta Partners VIII, L.P. reports a 0% stake in aTyr Pharma, Inc. |
| 07/10/2019 |
SC 13G/A
| FMR LLC reports a 15% stake in ATYR PHARMA INC |
| 06/10/2019 |
SC 13G/A
| FMR LLC reports a 9.1% stake in ATYR PHARMA INC |
| 02/14/2019 |
SC 13G/A
| Redmile Group, LLC reports a 2.3% stake in aTyr Pharma, Inc. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/10/2019 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 9.5% stake in aTyr Pharma, Inc. |
| 05/22/2018 |
SC 13G/A
| EcoR1 Capital, LLC reports a 2.3% stake in aTYR Pharma, Inc. |
| 02/14/2018 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 9.5% stake in aTyr Pharma, Inc. |
| 02/14/2018 |
SC 13G/A
| EcoR1 Capital, LLC reports a 15.2% stake in aTYR Pharma, Inc. |
| 02/13/2018 |
SC 13G/A
| FMR LLC reports a 15% stake in ATYR PHARMA INC |
| 02/06/2018 |
SC 13G/A
| Alta Partners VIII, L.P. reports a 6% stake in ATyr Pharma, Inc. |
| 09/07/2017 |
SC 13G/A
| EcoR1 Capital, LLC reports a 15.3% stake in aTYR Pharma, Inc. |
|
|
|